Gunderson Dettmer advised Cure Ventures on the deal. Cure Ventures announced the formation of its $350 million inaugural fund. Cure Ventures invests in early-stage life sciences...
Cure Ventures’ Formation of $350 Million Inaugural Fund
Volition Capital’s Formation of $675 Million Fund
Gunderson Dettmer represented Volition Capital on the deal. Volition Capital announced the formation of its $675 million fund, Volition Capital Fund V. The new fund totals over...
Matrix Partners’ Launch of Matrix Partners XII
Gunderson Dettmer represented Matrix Partners on the deal. Matrix Partners announced its $800 million fund, Matrix Partners XII. The company’s mission is to find entrepreneurs who combine...